Literature DB >> 23589509

Short-term impact of the smokefree legislation in England on emergency hospital admissions for asthma among adults: a population-based study.

Michelle Sims1, Roy Maxwell, Anna Gilmore.   

Abstract

BACKGROUND: Comprehensive smokefree laws have now been introduced in several jurisdictions. Few studies have examined the association between smokefree laws and asthma in adults and these have limitations, such as lacking appropriate adjustment for long-term trends or having limited statistical power due to small study populations. This study addresses these limitations and evaluates the short-term impact of smokefree legislation in England. It aims to investigate whether the introduction of smokefree legislation on 1 July 2007 was associated with an immediate reduction in emergency hospital admissions for asthma in the adult population, and whether any association differs across regions.
METHODS: We identified monthly numbers of emergency admissions for asthma (primary diagnosis, 10th revision of the International Classification of Diseases code J45 and J46) in the nine Government Office Regions from April 1997 to December 2010 in the population aged 16 and over. A generalised additive model was fitted that adjusted for seasonality, variation in population size and region-specific, non-linear, long-term trends.
RESULTS: Smokefree legislation was associated with an immediate 4.9% (95% CI 0.6% to 9.0%) reduction in emergency admissions for asthma in the adult population. This implies that approximately 1900 emergency admissions for asthma were prevented in each of the first 3 years after legislation was introduced. The reduction in admissions did not vary significantly across regions.
CONCLUSIONS: Our findings add to the expanding body of evidence that smokefree policies are associated with positive health outcomes. Further research evaluating the impact of legislation in other jurisdictions is needed to support these findings.

Entities:  

Keywords:  Asthma

Mesh:

Substances:

Year:  2013        PMID: 23589509     DOI: 10.1136/thoraxjnl-2012-202841

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

1.  Employed adults with asthma who have frequent workplace exposures.

Authors:  Gretchen E White; Jacek M Mazurek; Eileen Storey
Journal:  J Asthma       Date:  2014-07-29       Impact factor: 2.515

2.  Effect of Uruguay's National 100% Smokefree Law on Emergency Visits for Bronchospasm.

Authors:  Sara Kalkhoran; Ernesto M Sebrié; Edgardo Sandoya; Stanton A Glantz
Journal:  Am J Prev Med       Date:  2015-05-18       Impact factor: 5.043

3.  Association of Smoke-Free Laws With Lower Percentages of New and Current Smokers Among Adolescents and Young Adults: An 11-Year Longitudinal Study.

Authors:  Anna V Song; Lauren M Dutra; Torsten B Neilands; Stanton A Glantz
Journal:  JAMA Pediatr       Date:  2015-09-08       Impact factor: 16.193

Review 4.  Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption.

Authors:  Kate Frazer; Joanne E Callinan; Jack McHugh; Susan van Baarsel; Anna Clarke; Kirsten Doherty; Cecily Kelleher
Journal:  Cochrane Database Syst Rev       Date:  2016-02-04

5.  Impact of a countywide smoke-free workplace law on emergency department visits for respiratory diseases: a retrospective cohort study.

Authors:  Ivana T Croghan; Jon O Ebbert; J Taylor Hays; Darrell R Schroeder; Alanna M Chamberlain; Véronique L Roger; Richard D Hurt
Journal:  BMC Pulm Med       Date:  2015-01-22       Impact factor: 3.317

Review 6.  Smoking cessation strategies for patients with asthma: improving patient outcomes.

Authors:  Jennifer L Perret; Billie Bonevski; Christine F McDonald; Michael J Abramson
Journal:  J Asthma Allergy       Date:  2016-06-24

7.  Associations between community well-being and hospitalisation rates: results from a cross-sectional study within six US states.

Authors:  Brita Roy; Carley Riley; Jeph Herrin; Erica Spatz; Brent Hamar; Kenneth P Kell; Elizabeth Y Rula; Harlan Krumholz
Journal:  BMJ Open       Date:  2019-11-27       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.